Endocrinology, Diabetes & Metabolism Doctors in Aurora, IL Accepting Medicare

3 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 3

Padmalatha Berikai, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 2040 Ogden Ave, Suite 217, Aurora, IL 60504 Phone: 630-978-4889    Fax: 630-978-4913

Dr. Tharani Rajeswaran, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4100 Healthway Dr, Aurora, IL 60504 Phone: 630-851-3105    Fax: 630-978-6690

Dr. Betsy J Bennet, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1870 W Galena Blvd, Aurora, IL 60506 Phone: 630-859-6700    Fax: 630-859-6811

News Archive

Study: Logwood combustion emits substantial amount of secondary organic aerosols

Aerosol emissions from logwood combustion increase significantly when the emission ages in ambient air. A significant increase occurs already within three hours of aging, according to a new study from the University of Eastern Finland.

NSF grant puts talented undergraduates into research labs

Thirty undergraduate college students from around the nation will have the chance to spend a summer getting paid to explore the world of biological research, thanks to the efforts of scientists at the University of Rochester's Medical Center and River Campus.

Psychological stress in middle age increases risk of dementia later in life

Psychological stress in middle age could lead to the development of dementia later in life, especially Alzheimer's disease, reveals research from the University of Gothenburg, Sweden. Based on data from a study which followed women for 35 years, this is the first research in Sweden to indicate a link between stress and dementia.

CEVEC and Catalent Pharma Solutions offer joint cell line development service

CEVEC Pharmaceuticals, the German developer of a novel, market leading human protein expression system derived from amniocytes, and Catalent Pharma Solutions, a leading global drug development and delivery solutions provider, announced today a joint commercial cell line development service for pharma and biotech customers worldwide. The offering combines the benefits of CEVEC's human cell line, CAP-Technology, with Catalent's unique GPEx® (Gene Product Expression) Technology to generate high expressing stable human cell lines in a much shorter timeframe than traditional methods.

Read more Medical News

› Verified 8 days ago